893 related articles for article (PubMed ID: 22325219)
41. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
[TBL] [Abstract][Full Text] [Related]
42. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
43. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
44. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
[TBL] [Abstract][Full Text] [Related]
45. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
46. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro].
Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222
[TBL] [Abstract][Full Text] [Related]
47. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.
Chen XY; Li JS; Liang QP; He DZ; Zhao J
Chin Med J (Engl); 2008 May; 121(10):881-6. PubMed ID: 18706200
[TBL] [Abstract][Full Text] [Related]
48. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
49. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
[TBL] [Abstract][Full Text] [Related]
50. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.
Wada S; Noguchi T; Takeno S; Kawahara K
Ann Surg Oncol; 2006 Jul; 13(7):961-6. PubMed ID: 16788758
[TBL] [Abstract][Full Text] [Related]
51. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
52. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
54. [Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients].
Zheng ST; Liu T; Middottuersun A; Huo Q; Liu Q; Huang CG; Feng JG; Lü GD; Wang X; Lin RY; Sheyhidin I; Lu XM
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):421-5. PubMed ID: 21875481
[TBL] [Abstract][Full Text] [Related]
55. [Expression and clinical significance of Nrf2 in esophageal squamous cell carcinoma].
Mao JT; Tangsakar E; Shen H; Wang ZQ; Zhang MX; Chen JX; Zhang G; Wang JS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1231-3. PubMed ID: 22078454
[TBL] [Abstract][Full Text] [Related]
56. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma.
Faried A; Nakajima M; Sohda M; Miyazaki T; Kato H; Kuwano H
Eur J Surg Oncol; 2005 May; 31(4):410-4. PubMed ID: 15837049
[TBL] [Abstract][Full Text] [Related]
57. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
58. [Expression of MnSOD mRNA and protein in esophageal squamous cell carcinoma and its clinical significance].
Sun GG; Wang YD; Yu XR; Cheng YJ; Bai S; Liu Q; Zhang J; Yang XR; Wan X
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):834-7. PubMed ID: 21223689
[TBL] [Abstract][Full Text] [Related]
59. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Song Y; Wang Z; Liu X; Jiang W; Shi M
Ann Surg Oncol; 2012 Oct; 19(11):3606-12. PubMed ID: 22644515
[TBL] [Abstract][Full Text] [Related]
60. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
